Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer

UnknownOBSERVATIONAL
Enrollment

370

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2018

Conditions
Oral Squamous Cell Carcinoma
Interventions
OTHER

saliva collection prior to clinically driven oral biopsy

cell free saliva to be used to measure mRNA and proteins by PCR and ELISA

Trial Locations (5)

19096

RECRUITING

Main Line Health System, Wynnewood

48092

RECRUITING

St. John Providence Health System, Warren

48109

TERMINATED

University of Michigan, Ann Arbor

48912

TERMINATED

Department of Surgery, Michigan Sate University, East Lansing

60612

WITHDRAWN

University of Illinois at Chicago, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PeriRx

INDUSTRY